AU Patent

AU2021244559A1 — Non-viral DNA vectors and uses thereof for expressing Gaucher therapeutics

Assigned to Generation Bio Co · Expires 2022-11-17 · 3y expired

What this patent protects

The application describes ceDNA vectors having linear and continuous structure for delivery and expression of a transgene. ceDNA vectors comprise an expression cassette flanked by two ITR sequences, where the expression cassette encodes a transgene encoding GBA protein. Some ceDN…

USPTO Abstract

The application describes ceDNA vectors having linear and continuous structure for delivery and expression of a transgene. ceDNA vectors comprise an expression cassette flanked by two ITR sequences, where the expression cassette encodes a transgene encoding GBA protein. Some ceDNA vectors further comprise cis-regulatory elements, including regulatory switches. Further provided herein are methods and cell lines for reliable gene expression of GBA protein

Drugs covered by this patent

Patent Metadata

Patent number
AU2021244559A1
Jurisdiction
AU
Classification
—
Expires
2022-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Generation Bio Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.